SBI Securities’s TriSalus Life Sciences TLSI Stock Holding History

SBI Securities’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$9	–	4223
2025 Q3	$9	Buy	+2	New	+$9	﹤0.01%	4050

Other funds holding TLSI

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities's TLSI Position: Q4 2025 in Review

SBI Securities sold out of TriSalus Life Sciences (TLSI) in Q4 2025, closing a stake of 2 shares — an estimated $9 sold.

SBI Securities first reported a position in TLSI in Q3 2025 and held it in 1 quarter. The position peaked at $9 in Q3 2025. 67 funds tracked by Wall St. Rank hold TLSI as of Q4 2025.

SBI Securities reported no remaining TriSalus Life Sciences position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 2 TriSalus Life Sciences shares in Q4 2025, an estimated $9.
SBI Securities first reported a position in TriSalus Life Sciences in Q3 2025 and held it in 1 quarter.
SBI Securities's TriSalus Life Sciences position peaked at $9 in Q3 2025.
67 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.